Literature DB >> 31531924

Patient-centred care in haemophilia: Patient perspectives on visualization and participation in decision-making.

Erna C van Balen1, Marian Krawczyk2,3,4, Deborah Gue5, Shannon Jackson5, Samantha C Gouw1,6, Johanna G van der Bom1,7, Richard Sawatzky3,4,8.   

Abstract

INTRODUCTION AND AIM: The British Columbia Adult Haemophilia Team recently adopted a patient-centred care approach. The team presented visual information on an individual's pharmacokinetic profile and bleed history and encouraged patients to participate in treatment decisions. This qualitative study explored how this approach changed patients' understanding of haemophilia and how it facilitated them to make treatment decisions.
METHODS: We interviewed 18 males with mild, moderate or severe haemophilia, using a convenience sample from the adult haemophilia clinic at St. Paul's hospital in Vancouver, Canada. Interviews were recorded and transcribed verbatim and analyzed using descriptive content analysis.
RESULTS: Most participants reported that reviewing visual information with the Clinic Team helped them in their communication with their care providers during their annual review clinic appointment. Despite this improved communication, for some the most important feature of their treatment was that they had switched from on-demand treatment to prophylactic treatment in recent years and were able to prevent bleeds. Almost half of the participants reported that the visual information presented increased their understanding of haemophilia and the pharmacokinetics of coagulation factor. Three patients improved their treatment adherence or had changed their prophylaxis schedules based on this. Most participants felt that they were involved in decision-making about their treatment schedule, which they appreciated. On the other hand, two participants thought the Clinic Team should make these decisions.
CONCLUSION: Participants perceived the patient-centred prophylaxis approach helpful because it enhanced communication with the Clinic Team, increased their understanding of haemophilia and pharmacokinetics of coagulation factor and facilitated treatment decisions.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  adherence; patient-centred care; qualitative study; shared decision-making

Mesh:

Year:  2019        PMID: 31531924     DOI: 10.1111/hae.13830

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Patients' Perception of the Impact of Innovation on Hemophilia Care Management Organization: A Qualitative Study Protocol (INNOVHEMO Study).

Authors:  Karen Beny; Benjamin du Sartz de Vigneulles; Valerie Chamouard; Ronald Guilloux; Valérie Gay; Claude Negrier; Claude Dussart
Journal:  Patient Prefer Adherence       Date:  2021-08-18       Impact factor: 2.711

2.  Multiple criteria decision analysis for therapeutic innovations in a hemophilia care center: A pilot study of the organizational impact of innovation in hemophilia care management.

Authors:  Karen Beny; Amélie Dubromel; Benjamin du Sartz de Vigneulles; Valérie Gay; Florence Carrouel; Claude Negrier; Claude Dussart
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

3.  Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres.

Authors:  Matteo Nicola Dario Di Minno; Mariasanta Napolitano; Anna Chiara Giuffrida; Erminia Baldacci; Christian Carulli; Elena Boccalandro; Clarissa Bruno; Eleonora Forneris; Irene Ricca; Walter Passeri; Marco Martinelli; Gianna Franca Rivolta; Luigi Piero Solimeno; Carlo Martinoli; Angiola Rocino; Gianluigi Pasta
Journal:  Br J Haematol       Date:  2021-12-19       Impact factor: 8.615

4.  Do You Employ Shared Decision-Making in Your Practice?

Authors:  Beth Faiman
Journal:  J Adv Pract Oncol       Date:  2022-06-21

5.  Haemophilia in France: Modelisation of the Clinical Pathway for Patients.

Authors:  Karen Beny; Benjamin du Sartz de Vigneulles; Florence Carrouel; Denis Bourgeois; Valérie Gay; Claude Negrier; Claude Dussart
Journal:  Int J Environ Res Public Health       Date:  2022-01-06       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.